Department of Infectious Diseases and Hospital Epidemiology

The Department of Infectious Diseases and Hospital Epidemiology specializes in the outpatient and inpatient clarification and treatment of patients with all types of infectious diseases and immune defense disorders. In addition, the clinic is committed to the education and training of students and physicians.

Department of Infectious Diseases and Hospital Epidemiology

University Hospital Zurich
Raemistrasse 100
8091 Zurich
Tel. +41 44 255 33 22

Our research focuses on the following areas

  • HIV infection,
  • Transplant Infectious Diseases,
  • Bacterial virulence factors,
  • Biofilm production
  • as well as foreign body-associated infections.

Offer HIV treatment

Would you like to participate in an HIV clinical trial?

Our HIV consultation actively contributes to the development of new HIV therapies. We offer patients the opportunity to participate in clinical trials of new HIV drugs and thus contribute to HIV research.

We are currently looking for patients who have been newly diagnosed with HIV and have not yet started HIV therapy and are interested in participating in the DOMINO study. This study is investigating the efficacy and safety of a new class of drugs against HIV, called a maturation inhibitor, in combination with two commonly used HIV drugs.

Study participation is also possible for patients who are already receiving HIV treatment. In the MK-13 study, we are investigating a combination of two new HIV drugs that need to be taken only once a week instead of once a day. If you are interested in this study, please feel free to contact your HIV specialist or the study team.

Recruitment has been completed for another study, the SOLAR study. This study compares the efficacy and safety of two new drugs, called long-acting drugs, as an injection into the gluteal muscle every two months with standard treatment.

Before participating in any study, our medical team will carefully evaluate whether it would be safe and appropriate for you in the context of your medical history and current treatment. We welcome you to contact the study team at or directly at or